Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
caffeine | [no description available] | medium | 1 | 0 | purine alkaloid; trimethylxanthine | adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic |
andarine | [no description available] | medium | 1 | 0 | acetamides; anilide | |
guanabenz | [no description available] | medium | 7 | 4 | dichlorobenzene | |
nifedipine | [no description available] | medium | 8 | 5 | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
debrisoquin | [no description available] | medium | 3 | 2 | carboxamidine; isoquinolines | adrenergic agent; antihypertensive agent; human metabolite; sympatholytic agent |
propranolol | [no description available] | medium | 3 | 1 | naphthalenes; propanolamine; secondary amine | anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic |
methyldopa | [no description available] | medium | 1 | 0 | L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent |
acebutolol | [no description available] | medium | 4 | 2 | aromatic amide; ethanolamines; ether; monocarboxylic acid amide; propanolamine; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympathomimetic agent |
reserpine | [no description available] | medium | 7 | 4 | alkaloid ester; methyl ester; yohimban alkaloid | adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic |
ethacrynic acid | [no description available] | medium | 2 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic |
potassium nitrate | [no description available] | medium | 1 | 0 | inorganic nitrate salt; potassium salt | fertilizer |
urea | [no description available] | medium | 2 | 0 | isourea; monocarboxylic acid amide; one-carbon compound | Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
amiloride | [no description available] | medium | 1 | 0 | aromatic amine; guanidines; organochlorine compound; pyrazines | diuretic; sodium channel blocker |
furosemide | [no description available] | medium | 2 | 0 | chlorobenzoic acid; furans; sulfonamide | environmental contaminant; loop diuretic; xenobiotic |
bumetanide | [no description available] | medium | 1 | 0 | amino acid; benzoic acids; sulfonamide | diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor |
chlorine | [no description available] | medium | 1 | 0 | halide anion; monoatomic chlorine | cofactor; Escherichia coli metabolite; human metabolite |
nitrates | [no description available] | medium | 1 | 0 | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | |
glycosides | [no description available] | medium | 1 | 0 | | |
pteridines | [no description available] | medium | 1 | 0 | azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; pteridines | |
etozolin | [no description available] | medium | 1 | 1 | organonitrogen compound; organooxygen compound | |
inositol | [no description available] | medium | 5 | 3 | cyclitol; hexol | |
thiazoles | [no description available] | medium | 2 | 2 | 1,3-thiazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene | |
atenolol | [no description available] | medium | 3 | 2 | ethanolamines; monocarboxylic acid amide; propanolamine | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; sympatholytic agent; xenobiotic |
uric acid | [no description available] | medium | 3 | 1 | uric acid | Escherichia coli metabolite; human metabolite; mouse metabolite |
nitrendipine | [no description available] | medium | 2 | 2 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester | antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent |
alprenolol | [no description available] | medium | 3 | 0 | secondary alcohol; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
hydralazine | [no description available] | medium | 1 | 0 | azaarene; hydrazines; ortho-fused heteroarene; phthalazines | antihypertensive agent; vasodilator agent |
chlorthalidone | [no description available] | medium | 1 | 1 | isoindoles; monochlorobenzenes; sulfonamide | |
bendroflumethiazide | [no description available] | medium | 1 | 1 | benzothiadiazine; sulfonamide | antihypertensive agent; diuretic |
hydrochlorothiazide | [no description available] | medium | 1 | 1 | benzothiadiazine; organochlorine compound; sulfonamide | antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
albuterol | [no description available] | medium | 1 | 0 | phenols; phenylethanolamines; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; environmental contaminant; xenobiotic |
cyproterone | [no description available] | medium | 1 | 1 | 17alpha-hydroxy steroid; 20-oxo steroid; 3-oxo-Delta(4) steroid; chlorinated steroid; tertiary alpha-hydroxy ketone | androgen antagonist |
diethylstilbestrol | [no description available] | medium | 1 | 1 | olefinic compound; polyphenol | antifungal agent; antineoplastic agent; autophagy inducer; calcium channel blocker; carcinogenic agent; EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; endocrine disruptor; xenoestrogen |
dihydrotestosterone | [no description available] | medium | 1 | 1 | 17beta-hydroxy steroid; 17beta-hydroxyandrostan-3-one; 3-oxo-5alpha-steroid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite |
prednisone | [no description available] | medium | 1 | 1 | 11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | adrenergic agent; anti-inflammatory drug; antineoplastic agent; immunosuppressive agent; prodrug |
inositol niacinate | [no description available] | medium | 1 | 1 | inositol nicotinate | |
piperidines | [no description available] | medium | 1 | 1 | | |
spironolactone | [no description available] | medium | 1 | 1 | 3-oxo-Delta(4) steroid; oxaspiro compound; steroid lactone; thioester | aldosterone antagonist; antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
aldosterone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 18-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; mineralocorticoid; primary alpha-hydroxy ketone; steroid aldehyde | human metabolite; mouse metabolite |
amlodipine | [no description available] | medium | 1 | 1 | dihydropyridine; ethyl ester; methyl ester; monochlorobenzenes; primary amino compound | antihypertensive agent; calcium channel blocker; vasodilator agent |
dihydroergotoxine | [no description available] | medium | 1 | 1 | | |
xipamide | [no description available] | medium | 1 | 0 | benzamides | |
acetazolamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; sulfonamide; thiadiazoles | anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
diltiazem | [no description available] | medium | 1 | 0 | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent; calcium channel blocker; vasodilator agent |
isomethyleugenol | [no description available] | medium | 1 | 0 | isomethyleugenol | |
Acetylpheneturide | [no description available] | low | 0 | 0 | organic molecular entity | |
afloqualone | [no description available] | low | 0 | 0 | organic molecular entity | |
aranidipine | [no description available] | low | 0 | 0 | organic molecular entity | |
bromazepam | [no description available] | low | 0 | 0 | organic molecular entity | |
seratrodast | [no description available] | low | 0 | 0 | organic molecular entity | |
brotizolam | [no description available] | low | 0 | 0 | organic molecular entity | |
cadralazine | [no description available] | low | 0 | 0 | organic molecular entity | |
carbazilquinone | [no description available] | low | 0 | 0 | organic molecular entity | |
clinofibrate | [no description available] | low | 0 | 0 | organic molecular entity | |
clotiazepam | [no description available] | low | 0 | 0 | organic molecular entity | |
cyclofenil | [no description available] | low | 0 | 0 | organic molecular entity | |
ebastine | [no description available] | low | 0 | 0 | organic molecular entity | |
emorfazone | [no description available] | low | 0 | 0 | organic molecular entity | |
ethenzamide | [no description available] | low | 0 | 0 | organic molecular entity | |
ethyl loflazepate | [no description available] | low | 0 | 0 | organic molecular entity | |
etizolam | [no description available] | low | 0 | 0 | organic molecular entity | |
amidoline | [no description available] | low | 0 | 0 | organic molecular entity | |
floctafenine | [no description available] | low | 0 | 0 | organic molecular entity | |
flopropione | [no description available] | low | 0 | 0 | organic molecular entity | |
fp 83 | [no description available] | low | 0 | 0 | organic molecular entity | |
flutazolam | [no description available] | low | 0 | 0 | hemiaminal ether; organic molecular entity | |
flutoprazepam | [no description available] | low | 0 | 0 | organic molecular entity | |
glybuzole | [no description available] | low | 0 | 0 | organic molecular entity | |
haloxazolam | [no description available] | low | 0 | 0 | organic molecular entity | |
ibuprofen piconol | [no description available] | low | 0 | 0 | organic molecular entity | |
iothalamic acid | [no description available] | low | 0 | 0 | organic molecular entity | |
iotrolan | [no description available] | low | 0 | 0 | organic molecular entity | |
iotroxic acid | [no description available] | low | 0 | 0 | organic molecular entity | |
mazindol | [no description available] | low | 0 | 0 | organic molecular entity | |
medazepam | [no description available] | low | 0 | 0 | organic molecular entity | |
meprobamate | [no description available] | low | 0 | 0 | organic molecular entity | |
metharbital | [no description available] | low | 0 | 0 | organic molecular entity | |
methyprylon | [no description available] | low | 0 | 0 | organic molecular entity | |
myristicin | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
niceritrol | [no description available] | low | 0 | 0 | organic molecular entity | |
osalmide | [no description available] | low | 0 | 0 | organic molecular entity | |
oxazolam | [no description available] | low | 0 | 0 | hemiaminal ether; organic molecular entity | |
oxypertine | [no description available] | low | 0 | 0 | organic molecular entity | |
pirenoxine | [no description available] | low | 0 | 0 | organic molecular entity | |
propyliodone | [no description available] | low | 0 | 0 | organic molecular entity | |
repirinast | [no description available] | low | 0 | 0 | organic molecular entity | |
simfibrate | [no description available] | low | 0 | 0 | organic molecular entity | |
sobuzoxane | [no description available] | low | 0 | 0 | organic molecular entity | |
sulthiame | [no description available] | low | 0 | 0 | organic molecular entity | |
tazanolast | [no description available] | low | 0 | 0 | organic molecular entity | |
tofisopam | [no description available] | low | 0 | 0 | organic molecular entity | |
3-(2',4',5'-triethoxybenzoyl)propionic acid | [no description available] | low | 0 | 0 | organic molecular entity | |
vesnarinone | [no description available] | low | 0 | 0 | organic molecular entity | |
cn 100 | [no description available] | low | 0 | 0 | organic molecular entity | |
procaine hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
lysine | [no description available] | low | 0 | 0 | aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid | algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
Mebutamate | [no description available] | low | 0 | 0 | organic molecular entity | |
methandrostenolone | [no description available] | low | 0 | 0 | organic molecular entity | |
tetramethylammonium chloride | [no description available] | low | 0 | 0 | organic molecular entity | |
methsuximide | [no description available] | low | 0 | 0 | organic molecular entity | |
1-phenylpropanol | [no description available] | low | 0 | 0 | organic molecular entity | |
butylparaben | [no description available] | low | 0 | 0 | organic molecular entity | |
efloxate | [no description available] | low | 0 | 0 | organic molecular entity | |
sulfan blue | [no description available] | low | 0 | 0 | organic molecular entity | |
1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt | [no description available] | low | 0 | 0 | organic molecular entity | |
cycloguanil hydrochloride | [no description available] | low | 0 | 0 | hydrochloride; organic molecular entity | |
nicarbazin | [no description available] | low | 0 | 0 | organic molecular entity | |
fluocinonide | [no description available] | low | 0 | 0 | organic molecular entity | |
copper gluconate | [no description available] | low | 0 | 0 | organic molecular entity | |
naphazoline hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
doxylamine succinate | [no description available] | low | 0 | 0 | organic molecular entity | |
carbamylhydrazine monohydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
Berberine chloride (TN) | [no description available] | low | 0 | 0 | organic molecular entity | |
isosorbide | [no description available] | low | 0 | 0 | organic molecular entity | |
bucetin | [no description available] | low | 0 | 0 | organic molecular entity | |
tetradecyltrimethylammonium bromide | [no description available] | low | 0 | 0 | organic molecular entity | |
rimantadine hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
nitrofen | [no description available] | low | 0 | 0 | organic molecular entity | EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
perlapine | [no description available] | low | 0 | 0 | organic molecular entity | |
clorexolone | [no description available] | low | 0 | 0 | organic molecular entity | |
stavudine | [no description available] | low | 0 | 0 | dihydrofuran; nucleoside analogue; organic molecular entity | antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
iobenzamic acid | [no description available] | low | 0 | 0 | organic molecular entity | |
sulfamethomidine | [no description available] | low | 0 | 0 | organic molecular entity | |
Brilliant Blue | [no description available] | low | 0 | 0 | organic molecular entity | |
pyrodifenium bromide | [no description available] | low | 0 | 0 | organic molecular entity | |
didecyldimethylammonium chloride | [no description available] | low | 0 | 0 | organic molecular entity | |
iocarmic acid | [no description available] | low | 0 | 0 | organic molecular entity | |
bisoxatin acetate | [no description available] | low | 0 | 0 | organic molecular entity | |
levamisole hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
halazepam | [no description available] | low | 0 | 0 | organic molecular entity | |
nicomol | [no description available] | low | 0 | 0 | organic molecular entity | |
feprazone | [no description available] | low | 0 | 0 | organic molecular entity | |
b 10610 | [no description available] | low | 0 | 0 | organic molecular entity | |
haloperidol decanoate | [no description available] | low | 0 | 0 | organic molecular entity | |
pinacidil | [no description available] | low | 0 | 0 | organic molecular entity | |
loxiglumide | [no description available] | low | 0 | 0 | organic molecular entity | |
saquinavir monomethanesulfonate | [no description available] | low | 0 | 0 | organic molecular entity | |
Pronetalol hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
phenelzine sulfate | [no description available] | low | 0 | 0 | organic molecular entity | |
magnesium peroxide | [no description available] | low | 0 | 0 | organic molecular entity | |
dexamethasone 21-palmitate | [no description available] | low | 0 | 0 | organic molecular entity | |
rotenolone | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
nilverm | [no description available] | low | 0 | 0 | organic molecular entity | |
diumide | [no description available] | low | 0 | 0 | organic molecular entity | |
docarpamine | [no description available] | low | 0 | 0 | organic molecular entity | |
clobetasone butyrate | [no description available] | low | 0 | 0 | organic molecular entity | |
enocitabine | [no description available] | low | 0 | 0 | organic molecular entity | |
ranimustine | [no description available] | low | 0 | 0 | organic molecular entity | |
protizinic acid | [no description available] | low | 0 | 0 | organic molecular entity | |
nipradilol | [no description available] | low | 0 | 0 | organic molecular entity | |
panipenem | [no description available] | low | 0 | 0 | organic molecular entity | |
p-Aminobenzamidine dihydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
aucubin | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
catalpol | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
halopredone acetate | [no description available] | low | 0 | 0 | organic molecular entity | |
3-acetyllupeol | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
phenmetrazine hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
isometamidium chloride | [no description available] | low | 0 | 0 | organic molecular entity | |
melanotan-ii | [no description available] | low | 0 | 0 | organic molecular entity | |
anecortave acetate | [no description available] | low | 0 | 0 | organic molecular entity | |
aluminum phthalocyanine | [no description available] | low | 0 | 0 | organic molecular entity | |
olprinone | [no description available] | low | 0 | 0 | organic molecular entity | |
clidanac | [no description available] | low | 0 | 0 | organic molecular entity | |
enkephalin-met, arg(6)-phe(7)- | [no description available] | low | 0 | 0 | organic molecular entity | |
angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- | [no description available] | low | 0 | 0 | organic molecular entity | |
ramatroban | [no description available] | low | 0 | 0 | organic molecular entity | |
3-acetylpyridine adenine dinucleotide | [no description available] | low | 0 | 0 | organic molecular entity | |
iguratimod | [no description available] | low | 0 | 0 | organic molecular entity | |
blonanserin | [no description available] | low | 0 | 0 | organic molecular entity | |
fudosteine | [no description available] | low | 0 | 0 | organic molecular entity | |
perlolyrine | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
timepidium bromide | [no description available] | low | 0 | 0 | organic molecular entity | |
2-(2-hydroxy-4-methylphenyl)aminothiazole | [no description available] | low | 0 | 0 | organic molecular entity | |
cupric hydroxide | [no description available] | low | 0 | 0 | organic molecular entity | |
beta-mercaptolactate cysteine disulfide | [no description available] | low | 0 | 0 | organic molecular entity | |
s 8308 | [no description available] | low | 0 | 0 | organic molecular entity | |
farrerol | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
hydroxylamine hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
cyclo(l-phe-l-pro) | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
gestonorone caproate | [no description available] | low | 0 | 0 | organic molecular entity | |
epitiostanol | [no description available] | low | 0 | 0 | organic molecular entity | |
halcinonide | [no description available] | low | 0 | 0 | organic molecular entity | SMO receptor agonist |
oxendolone | [no description available] | low | 0 | 0 | organic molecular entity | |
dironyl | [no description available] | low | 0 | 0 | organic molecular entity | |
ao 128 | [no description available] | low | 0 | 0 | organic molecular entity | |
ditiocarb sodium | [no description available] | low | 0 | 0 | organic molecular entity | |
aceglatone | [no description available] | low | 0 | 0 | organic molecular entity | |
opc-2009 | [no description available] | low | 0 | 0 | organic molecular entity | |
bucillamine | [no description available] | low | 0 | 0 | organic molecular entity | |
cefsulodin sodium | [no description available] | low | 0 | 0 | organic molecular entity | |
n-(3,4-dimethoxyphenyl)-n-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-4-nitrobenzamide hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
4E2RCat | [no description available] | low | 0 | 0 | organic molecular entity | |
potassium oxonate | [no description available] | low | 0 | 0 | organic molecular entity | |
p-aminosalicylic acid monosodium salt | [no description available] | low | 0 | 0 | organic molecular entity | |
1-deoxyfructose | [no description available] | low | 0 | 0 | organic molecular entity | |
ungeremine | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
ethyl 4-(3-oxo-2,3-dihydroisothiazol-2-yl)benzoate | [no description available] | low | 0 | 0 | organic molecular entity | |
pyrantel pamoate | [no description available] | low | 0 | 0 | organic molecular entity | |
chlorpheniramine maleate | [no description available] | low | 0 | 0 | organic molecular entity | |
dexchlorpheniramine maleate | [no description available] | low | 0 | 0 | organic molecular entity | |
gsh-prostaglandin a1 | [no description available] | low | 0 | 0 | organic molecular entity | |
lafutidine | [no description available] | low | 0 | 0 | organic molecular entity | |
pheniramine maleate | [no description available] | low | 0 | 0 | organic molecular entity | |
sf 837 | [no description available] | low | 0 | 0 | organic molecular entity | |
gefarnate | [no description available] | low | 0 | 0 | organic molecular entity | |
sorivudine | [no description available] | low | 0 | 0 | organic molecular entity | |
ornoprostil | [no description available] | low | 0 | 0 | organic molecular entity | |
cd 3400 | [no description available] | low | 0 | 0 | organic molecular entity | |
rokitamycin | [no description available] | low | 0 | 0 | organic molecular entity | |
prednisolone farnesylate | [no description available] | low | 0 | 0 | organic molecular entity | |
dinoprost tromethamine | [no description available] | low | 0 | 0 | organic molecular entity | |
phenoxybenzamine hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
proscillaridin | [no description available] | low | 0 | 0 | organic molecular entity | |
goserelin | [no description available] | low | 0 | 0 | organic molecular entity | |
azodicarbonamide | [no description available] | low | 0 | 0 | organic molecular entity | |
tulobuterol hydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
maxacalcitol | [no description available] | low | 0 | 0 | organic molecular entity | |
longiborneol | [no description available] | low | 0 | 0 | organic molecular entity | |
falcarindiol | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
ozagrel, monohydrochloride, (e)-isomer | [no description available] | low | 0 | 0 | organic molecular entity | |
microcystin rr | [no description available] | low | 0 | 0 | microcystin; organic molecular entity | bacterial metabolite; environmental contaminant; xenobiotic |
lankacidins | [no description available] | low | 0 | 0 | organic molecular entity | |
romurtide | [no description available] | low | 0 | 0 | organic molecular entity | |
ciclesonide | [no description available] | low | 0 | 0 | organic molecular entity | |
fursultiamin monohydrochloride | [no description available] | low | 0 | 0 | organic molecular entity | |
pentagastrin | [no description available] | low | 0 | 0 | organic molecular entity | |
mepitiostane | [no description available] | low | 0 | 0 | organic molecular entity | |
calcium sulfide | [no description available] | low | 0 | 0 | organic molecular entity | |
barettin | [no description available] | low | 0 | 0 | organic molecular entity | |
8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide, (r)-isomer, | [no description available] | low | 0 | 0 | organic molecular entity | |
nociceptin | [no description available] | low | 0 | 0 | organic molecular entity; polypeptide | human metabolite; rat metabolite |
sodium salicylate | [no description available] | low | 0 | 0 | organic molecular entity | |
n-(2-methylbenzyl)linoleamide | [no description available] | low | 0 | 0 | organic molecular entity | |
halisulfate 1 | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
novobiocin sodium | [no description available] | low | 0 | 0 | organic molecular entity | |
cefoperazone sodium | [no description available] | low | 0 | 0 | organic molecular entity | |
osteum | [no description available] | low | 0 | 0 | organic molecular entity | |
cefoxitin sodium | [no description available] | low | 0 | 0 | organic molecular entity | |
dexon (fungicide), sodium salt | [no description available] | low | 0 | 0 | organic molecular entity | |
zinacef | [no description available] | low | 0 | 0 | organic molecular entity | |
sodium iodate | [no description available] | low | 0 | 0 | organic molecular entity | |
pyrithiobac sodium | [no description available] | low | 0 | 0 | organic molecular entity | |
cortisol succinate, sodium salt | [no description available] | low | 0 | 0 | organic molecular entity | |
sodium 2,6-dichloroindophenol | [no description available] | low | 0 | 0 | organic molecular entity | |
quinupristin-dalfopristin | [no description available] | low | 0 | 0 | organic molecular entity | |
gyy 4137 | [no description available] | low | 0 | 0 | organic molecular entity | |
monanchocidin | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
spinetoram | [no description available] | low | 0 | 0 | organic molecular entity | |
gimeracil | [no description available] | low | 0 | 0 | organic molecular entity | |
suvanine | [no description available] | low | 0 | 0 | organic molecular entity | metabolite |
vt-1161 | [no description available] | low | 0 | 0 | organic molecular entity | |
3-hydroxykynurenine glucoside | [no description available] | low | 0 | 0 | organic molecular entity | |
dBET6 | [no description available] | low | 0 | 0 | organic molecular entity | |
MZ1 | [no description available] | low | 0 | 0 | organic molecular entity | |
staphylopine(1-) | [no description available] | low | 0 | 0 | organic molecular entity | |
pseudopaline(2-) | [no description available] | low | 0 | 0 | organic molecular entity | |
valtrex | [no description available] | low | 0 | 0 | organic molecular entity | |
hlo 7 | [no description available] | low | 0 | 0 | organic molecular entity | |
7-deazaguanine | [no description available] | low | 0 | 0 | organic molecular entity | |
7,8-dihydropterin | [no description available] | low | 0 | 0 | organic molecular entity; pterins | |
pteroylpentaglutamic acid | [no description available] | low | 0 | 0 | organic molecular entity | |
amicoumacin a | [no description available] | low | 0 | 0 | organic molecular entity | |